同興科技(003027.SZ):公司S-NFPP(高首充磷酸焦磷酸鐵鈉)鈉電材料已進入中試投產階段
格隆匯4月3日丨同興科技(003027.SZ)在投資者互動平台表示,公司S-NFPP(高首充磷酸焦磷酸鐵鈉)鈉電材料已進入中試投產階段。結合NFPP和補鈉劑製備的S-NFPP材料克容量發揮和首效提高成效顯著。採用高首充S-NFPP鈉電材料組裝的全電池,首圈效率由85.5%提升到了97.5%,公司S-NFPP材料具有更好的能量密度、循環性能和低成本等優勢。目前,年產2萬噸鈉離子電池正極材料項目工廠初步規劃已完成,後期建設將根據產品、市場需求等多重因素綜合考慮確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.